FDA Panel Supports Lifting Restrictions on Four Peptides

In an all-day hearing, the agency’s scientists argued against allowing broad access to unproven drugs that the agency had banned three years ago.

Source: [NYT Politics](https://www.nytimes.com/2026/07/23/health/fda-scientists-rfk-peptides.html)